A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants

The current COVID-19 pandemic has heavily burdened the global public health system and may keep simmering for years. The frequent emergence of immune escape variants have spurred the search for prophylactic vaccines and therapeutic antibodies that confer broad protection against SARS-CoV-2 variants....

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhenlin, Wang, Yulu, Jin, Yujia, Zhu, Yuanfei, Wu, Yanling, Li, Cheng, Kong, Yu, Song, Wenping, Tian, Xiaolong, Zhan, Wuqiang, Huang, Ailing, Zhou, Shanshan, Xia, Shuai, Tian, Xiaoxu, Peng, Chao, Chen, Cuicui, Shi, Yibing, Hu, Gaowei, Du, Shujuan, Wang, Yuyan, Xie, Youhua, Jiang, Shibo, Lu, Lu, Sun, Lei, Song, Yuanlin, Ying, Tianlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564274/
https://www.ncbi.nlm.nih.gov/pubmed/34732694
http://dx.doi.org/10.1038/s41392-021-00810-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564274/
https://www.ncbi.nlm.nih.gov/pubmed/34732694
http://dx.doi.org/10.1038/s41392-021-00810-1

Ejemplares similares